Compliance and Efficacy in the Use of PICOPREP®

Overview

The present trial is aimed to document efficacy (bowel cleanliness), acceptance and tolerability as well as patient comfort in the use of the new bowel cleansing product PICOPREP® in every day practice. In particular, it should be evaluated, whether bowel cleanliness, acceptance, tolerability and patient comfort are affected by specific practice procedures, changes in dose etc.

Full Title of Study: “Compliance and Efficacy in the Use of PICOPREP® for Bowel Cleansing”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: May 2011

Clinical Trial Outcome Measures

Primary Measures

  • Documentation of the use of PICOPREP® in every day practice
    • Time Frame: 2 days
    • Will evaluate efficacy (bowel cleanliness), compliance, acceptance, tolerability and patient comfort

Secondary Measures

  • Documentation of patient satisfaction after bowel cleansing
    • Time Frame: 2 days
  • Documentation of examiner satisfaction after colonoscopy
    • Time Frame: 2 days
  • Identification of patient groups in which bowel cleansing is more difficult due to concomitant diseases or other conditions (risk groups)
    • Time Frame: 2 days
  • Tolerability: frequency and severity of adverse events
    • Time Frame: 2 days

Participating in This Clinical Trial

Inclusion Criteria

  • Patients receiving PICOPREP® for bowel evacuation prior to endoscopy or surgery – Patients who have been informed about the NIS and have given their written consent for participation Exclusion Criteria:

  • Patients in which prescription of PICOPREP® is contraindicated

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Ferring Pharmaceuticals
  • Collaborator
    • Ferring Arzneimittel GmbH
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Clinical Development Support, Study Director, Ferring Pharmaceuticals

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.